These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 1323566)
41. Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family. Bergstrom DA; Tapscott SJ Mol Cell Biol; 2001 Apr; 21(7):2404-12. PubMed ID: 11259589 [TBL] [Abstract][Full Text] [Related]
42. Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD. Lau P; Bailey P; Dowhan DH; Muscat GE Nucleic Acids Res; 1999 Jan; 27(2):411-20. PubMed ID: 9862959 [TBL] [Abstract][Full Text] [Related]
43. Serum-induced inhibition of myogenesis is differentially relieved by retinoic acid and triiodothyronine in C2 murine muscle cells. Albagli-Curiel O; Carnac G; Vandromme M; Vincent S; Crépieux P; Bonnieu A Differentiation; 1993 Mar; 52(3):201-10. PubMed ID: 8387038 [TBL] [Abstract][Full Text] [Related]
44. MyoR: a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD. Lu J; Webb R; Richardson JA; Olson EN Proc Natl Acad Sci U S A; 1999 Jan; 96(2):552-7. PubMed ID: 9892671 [TBL] [Abstract][Full Text] [Related]
45. Positive autoregulation of the myogenic determination gene MyoD1. Thayer MJ; Tapscott SJ; Davis RL; Wright WE; Lassar AB; Weintraub H Cell; 1989 Jul; 58(2):241-8. PubMed ID: 2546677 [TBL] [Abstract][Full Text] [Related]
46. Physical interaction between the mitogen-responsive serum response factor and myogenic basic-helix-loop-helix proteins. Groisman R; Masutani H; Leibovitch MP; Robin P; Soudant I; Trouche D; Harel-Bellan A J Biol Chem; 1996 Mar; 271(9):5258-64. PubMed ID: 8617811 [TBL] [Abstract][Full Text] [Related]
47. Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family. Downes M; Carozzi AJ; Muscat GE Mol Endocrinol; 1995 Dec; 9(12):1666-78. PubMed ID: 8614403 [TBL] [Abstract][Full Text] [Related]
48. The MRF4 activation domain is required to induce muscle-specific gene expression. Mak KL; To RQ; Kong Y; Konieczny SF Mol Cell Biol; 1992 Oct; 12(10):4334-46. PubMed ID: 1328851 [TBL] [Abstract][Full Text] [Related]
49. SV40 large T inhibits myogenic differentiation partially through inducing c-jun. Endo T J Biochem; 1992 Sep; 112(3):321-9. PubMed ID: 1331038 [TBL] [Abstract][Full Text] [Related]
50. ZEB, a vertebrate homolog of Drosophila Zfh-1, is a negative regulator of muscle differentiation. Postigo AA; Dean DC EMBO J; 1997 Jul; 16(13):3935-43. PubMed ID: 9233803 [TBL] [Abstract][Full Text] [Related]
51. Quantification of MyoD, myogenin, MRF4 and Id-1 by reverse-transcriptase polymerase chain reaction in rat muscles--effects of hypothyroidism and chronic low-frequency stimulation. Kraus B; Pette D Eur J Biochem; 1997 Jul; 247(1):98-106. PubMed ID: 9249014 [TBL] [Abstract][Full Text] [Related]
52. Antisense inhibition of myoD expression in regenerating rat soleus muscle is followed by an increase in the mRNA levels of myoD, myf-5 and myogenin and by a retarded regeneration. Zádor E; Bottka S; Wuytack F Biochim Biophys Acta; 2002 Jun; 1590(1-3):52-63. PubMed ID: 12063168 [TBL] [Abstract][Full Text] [Related]
53. Doxorubicin represses the function of the myogenic helix-loop-helix transcription factor MyoD. Involvement of Id gene induction. Kurabayashi M; Jeyaseelan R; Kedes L J Biol Chem; 1994 Feb; 269(8):6031-9. PubMed ID: 8119948 [TBL] [Abstract][Full Text] [Related]
54. cis-4-Hydroxy-L-proline and ethyl-3,4-dihydroxybenzoate prevent myogenesis of C2C12 muscle cells and block MyoD1 and myogenin expression. Saitoh O; Periasamy M; Kan M; Matsuda R Exp Cell Res; 1992 May; 200(1):70-6. PubMed ID: 1373388 [TBL] [Abstract][Full Text] [Related]
55. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein. Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518 [TBL] [Abstract][Full Text] [Related]
56. Antineoplastic agent doxorubicin inhibits myogenic differentiation of C2 myoblasts. Kurabayashi M; Jeyaseelan R; Kedes L J Biol Chem; 1993 Mar; 268(8):5524-9. PubMed ID: 8449915 [TBL] [Abstract][Full Text] [Related]
57. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Rohwedel J; Maltsev V; Bober E; Arnold HH; Hescheler J; Wobus AM Dev Biol; 1994 Jul; 164(1):87-101. PubMed ID: 8026639 [TBL] [Abstract][Full Text] [Related]
58. E1A-mediated inhibition of myogenesis correlates with a direct physical interaction of E1A12S and basic helix-loop-helix proteins. Taylor DA; Kraus VB; Schwarz JJ; Olson EN; Kraus WE Mol Cell Biol; 1993 Aug; 13(8):4714-27. PubMed ID: 8393137 [TBL] [Abstract][Full Text] [Related]
59. Repression of myogenin function by TGF-beta 1 is targeted at the basic helix-loop-helix motif and is independent of E2A products. Martin JF; Li L; Olson EN J Biol Chem; 1992 Jun; 267(16):10956-60. PubMed ID: 1317849 [TBL] [Abstract][Full Text] [Related]
60. Terminal differentiation and growth inhibition of a rat rhabdomyosarcoma cell line (BA-HAN-1C) in vitro after exposure to retinoic acid. Gabbert HE; Gerharz CD; Biesalski HK; Engers R; Luley C Cancer Res; 1988 Sep; 48(18):5264-9. PubMed ID: 3409249 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]